Posted in | News | Biosensors

TriEye and Vertilas Partner to Demonstrate 1.3µm VCSEL-Driven SWIR Sensing Solutions

TriEye, pioneer of the world's first cost-effective mass-market Short-Wave Infrared (SWIR) sensing technology, and Vertilas GmbH, a leader in InP VCSEL products, announced today the joint demonstration of a 1.3μm VCSEL-powered SWIR sensing system. TriEye and Vertilas announce their collaboration in advanced imaging technology.

This partnership has led to the development of a technology demonstrator that integrates TriEye's state-of-the-art Short-Wave Infrared (SWIR) Raven image sensor with Vertilas’ innovative Indium Phosphide (InP) Vertical-Cavity Surface-Emitting Laser (VCSEL) technology.

Adopting high-volume, scalable manufacturing strategies, these technologies provide cost-effective solutions for both consumer and industrial markets. The system highlights the capabilities of TriEye's CMOS-based SWIR sensor, noted for its high sensitivity and 1.3MP resolution.

Designed to enhance imaging in various industries, including automotive, consumer, biometrics, and mobile robots, this solution represents a significant step forward in sensing technology. Alongside, Vertilas introduces its InP SWIR VCSEL technology that provides high output power with high power efficiency.

This new VCSEL technology is a complementary innovation that enhances the SWIR camera's functionality. Deploying 1.3µm VCSEL arrays enables greatly improved eye safety and signal quality while minimizing sunlight distortion. Vertilas InP VCSEL array technology also offers wavelengths at 1.55µm up to 2µm. This new technology is expected to broaden the scope of applications in imaging and illumination across multiple industries.

"Vertilas is thrilled to expand our efforts with TriEye in this groundbreaking initiative. Our InP VCSEL technology, combined with TriEye's exceptional SWIR sensor, marks a significant advancement in the realm of imaging and illumination solutions”

Christian Neumeyr, CEO at Vertilas

Christian adds, “This collaboration is more than just a technological achievement; it represents our shared vision of innovating for a better, more efficient future in both consumer and industrial applications."

"At TriEye, our commitment has always been to bring revolutionary SWIR technology to the forefront of the market. The integration of our SWIR sensor with Vertilas InP VCSEL technology in this collaborative venture is a testament to this mission”

Avi Bakal, CEO of TriEye.

Avi adds, “We are proud to unveil a solution that not only enhances imaging capabilities across various industries but also does so in a cost-effective and scalable manner, making advanced sensing technology more accessible than ever."

Join us at the CS International Conference in Brussels

You're invited to explore our technologies at the Vertilas booth during the CS International Conference, hosted at the Sheraton Brussels Airport Hotel on April 16- 17, 2024. Discover how our collaborative efforts are shaping the future of SWIR sensing technology. For further details or business inquiries, please contact us at [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TriEye. (2024, April 15). TriEye and Vertilas Partner to Demonstrate 1.3µm VCSEL-Driven SWIR Sensing Solutions. AZoSensors. Retrieved on May 30, 2024 from https://www.azosensors.com/news.aspx?newsID=15798.

  • MLA

    TriEye. "TriEye and Vertilas Partner to Demonstrate 1.3µm VCSEL-Driven SWIR Sensing Solutions". AZoSensors. 30 May 2024. <https://www.azosensors.com/news.aspx?newsID=15798>.

  • Chicago

    TriEye. "TriEye and Vertilas Partner to Demonstrate 1.3µm VCSEL-Driven SWIR Sensing Solutions". AZoSensors. https://www.azosensors.com/news.aspx?newsID=15798. (accessed May 30, 2024).

  • Harvard

    TriEye. 2024. TriEye and Vertilas Partner to Demonstrate 1.3µm VCSEL-Driven SWIR Sensing Solutions. AZoSensors, viewed 30 May 2024, https://www.azosensors.com/news.aspx?newsID=15798.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.